The U.S. Preventive Services Task Force is warning that unnecessary testing for the breast cancer gene could potentially cause harm.  Academy Award winning actress Angelina Jolie revealed shocking news in May that she’d undergone a preventive double mastectomy after learning that she carried the cancer gene mutation known as BRCA-1.  Her announcement sparked huge interest among women in genetic testing.  But the U.S. panel warned yesterday against routine genetic testing for women whose family history is not associated with an increased risk for BRCA-1 or BRCA-2 mutations.

(The Associated Press)